Skip to content

Draximage, Inc.

CanadaFDA 510(k) applicant, unverified

Devices
2

What Draximage, Inc. makes

Draximage, Inc. manufactures brachytherapy seed implants, including the PD-103 models (#PD1) and generic brachyseeds designed for permanent interstitial radiation therapy.

These devices are classified as Class II under FDA regulations and are supported by 510(k) clearances. The company is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue2

Newest first, rows 1-2 of 2

  • Brachyseed Pd-103 Models #PD1 Ref K011119

    Class II
    Active 510(k) 510(k) II
  • Brachyseed Ref K000475

    Class II
    Active 510(k) 510(k) II

Frequently asked questions

How many devices does Draximage, Inc. have in the registry?

The registry currently lists 2 devices for Draximage, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Draximage, Inc.'s devices?

Among its 2 most recently registered devices, Draximage, Inc. has devices listed in FDA 510(k) (2 devices).

What risk classes do Draximage, Inc.'s devices fall under?

Among its 2 most recently registered devices, the classes recorded for Draximage, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Draximage, Inc. in the registry?

The most recently registered devices listed for Draximage, Inc. include BRACHYSEED PD-103 MODELS #PD1 and BRACHYSEED.

Generated automatically from registry data and not verified by a human reviewer.